Ken Griffin Generation Bio Co. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$2.64 - $4.35 $528 - $869	200 New	200 $0
Q3 2023 Nov 14, 2023	SELL	$3.65 - $6.9 $2,920 - $5,520	-800 Reduced 14.81%	4,600 $17,000
Q2 2023 Aug 14, 2023	BUY	$3.5 - $5.67 $10,850 - $17,577	3,100 Added 134.78%	5,400 $29,000
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $4,693 - $9,113	1,300 Added 130.0%	2,300 $9,000
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $3,660 - $6,770	1,000 New	1,000 $3,000

50M

100

200

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $169M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.